Useful resources |
Cardioprotective interventions for cancer patients receiving anthracyclines (Cochrane Review) ABSTRACT Background: Anthracyclines are among the most effective chemotherapeutic agents in the treatment of numerous malignancies. Unfortunately, their use is limited by a dose-dependent cardiotoxicity. In an effort to prevent this cardiotoxicity, different cardioprotec . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |